US stalls on pounds 202m sale of Fisons arm
Saturday 01 July 1995
Fisons' merger with rival drugs group Medeva looked set to be held up by news yesterday that US competition authorities were delaying the pounds 202m sale of the scientific instruments division.
Fisons, based in Ipswich, said the Federal Trade Commission and other US competition authorities had "expressed concern" that the sale to Thermo Instruments Systems Inc could affect competition in the markets for some of the instruments involved.
As a result, the date for completion of the sale had been extended by mutual agreement from the previously announced date of yesterday to 15 August.
Analysts believe that the proceeds from the deal would help smooth the path to a takeover of Medeva, with which talks have been under way since early April, in a deal mooted at between pounds 800m and pounds 1bn. Fisons refused to comment yesterday on the impact of the latest news on the negotiations, but it sought to play down the significance of the FTC ruling.
A representative said "a very small proportion" of the instruments business was involved in the discussions with the authorities over competition. The operations involved represented only 10 per cent of the sales of the division, which last year amounted to pounds 260m out of a total for the whole Fisons group of pounds 1.27bn. She added that such competition investigations were routine events in the US.
Analysts said the news was more of a nuisance than a disaster for the Medeva deal. Paul Diggle at Societe Generale Strauss Turnbull said: "People still expect a deal to be done and that there will have to be a cash alternative. Money in the bank will be helpful for that, but I don't think what happened today will make a transaction significantly less likely, it will just make the issues surrounding it more awkward."
Fisons had been hoping to have tied up disposals to give it net cash of close to pounds 500m by now, he suggested, but as a result of the delay it would be in "a slightly less comfortable position". Last month, Fisons sold its research and development arm to Astra of Sweden for pounds 202m and is negotiating to sell a laboratory supplies business.
Anthony Colletta, of Hoare Govett, was less sanguine, suggesting it would not help sentiment. "There is already a rumour going round the market that Fisons is ready to issue an awful lot of deeply-discounted paper to pay for Medeva. I think that would be viewed in a very bad light."
- 1 Unseen Charlie and the Chocolate Factory chapter deemed 'too subversive' released
- 3 Joan Rivers: 'Palestinians deserve to be dead'
- 4 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
- 5 Mexican woman becomes world’s 'oldest person' at 127
Israel-Gaza crisis: YouTube footage shows scale of destruction after 50 days of shelling
iPhone 6 'hidden code' could indicate sharper screens or bigger phones
Keira Knightley topless: Conservative actress does own take on #Freethenipple campaign for Interview Magazine
Joan Rivers: 'Palestinians deserve to be dead'
Ebola virus: It's ripped through towns – now the deadliest ever outbreak of the virus is heading for Africa's teeming cities
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
Rotherham child sex abuse scandal: Labour Home Office to be probed over what Tony Blair's government knew - and when
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
What do immigrants really think of Britain? Polish immigrant's Reddit post goes viral
Do you realise just how foolish the UK looks?
With Douglas Carswell joining Ukip, my party has taken another giant step forward
iJobs Money & Business
£40000 - £45000 per annum: Ashdown Group: An established professional services...
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
£28 - 32k + Uncapped Commission: Guru Careers: A Business Development Manager ...
£40000 - £70000 per annum + Bonus+Benefits+Package: Harrington Starr: C# .NET ...